Skip to content
ChickenStockChickenStock
ResearchFilings

AI English summary of an SEC filing — figures as filed

Cigna logoCigna CI

The Cigna Group completed its offering of $1,000,000,000 in 4.500% Senior Notes due 2030, $1,250,000,000 in 4.875% Senior Notes due 2032, $1,500,000,000 in 5.250% Senior Notes due 2036 and $750,000,000 in 6.000% Senior Notes due 2056 on September 4, 2025.

8-KEntry into a Material Definitive AgreementFiled Period of report Summary published (UTC)

Key points

AI summary
  1. The Cigna Group completed its offering of $1,000,000,000 in 4.500% Senior Notes due 2030, $1,250,000,000 in 4.875% Senior Notes due 2032, $1,500,000,000 in 5.250% Senior Notes due 2036 and $750,000,000 in 6.000% Senior Notes due 2056 on September 4, 2025.

  2. The company said it intends to use the proceeds to repay $2.0 billion of loans outstanding under a Term Loan Agreement dated as of August 5, 2025, the proceeds of which were used to fund a strategic investment in another company, and the remainder for general corporate purposes, which may include investments and repayment of indebtedness.

  3. The company said interest on the 2030 and 2032 Notes will be payable on March 15 and September 15 of each year, and interest on the 2036 and 2056 Notes will be payable on January 15 and July 15 of each year, with maturity dates of September 15, 2030, September 15, 2032, January 15, 2036 and January 15, 2056, respectively.

  4. The company said it may redeem each series of Notes prior to specified dates by paying a make-whole premium plus accrued and unpaid interest, and on or after such dates by paying a redemption price equal to 100% of the principal amount plus accrued and unpaid interest. The company entered into an Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC on September 2, 2025.

Summary

AI-written

Analysis scope · Filing bodyWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

Completion of 4 Series of Senior Notes Offering on September 4, 2025

The Cigna Group completed its offering of $1,000,000,000 in 4.500% Senior Notes due 2030, $1,250,000,000 in 4.875% Senior Notes due 2032, $1,500,000,000 in 5.250% Senior Notes due 2036 and $750,000,000 in 6.000% Senior Notes due 2056 on September 4, 2025.

Source · Based on the filing body and exhibits

Use of Proceeds

The company said it intends to use the proceeds to repay $2.0 billion of loans outstanding under a Term Loan Agreement dated as of August 5, 2025, the proceeds of which were used to fund a strategic investment in another company, and the remainder for general corporate purposes, which may include investments and repayment of indebtedness.

Source · Based on the filing body and exhibits

Interest Payment Dates and Maturity Dates by Note

The company said interest on the 2030 and 2032 Notes will be payable on March 15 and September 15 of each year, and interest on the 2036 and 2056 Notes will be payable on January 15 and July 15 of each year, with maturity dates of September 15, 2030, September 15, 2032, January 15, 2036 and January 15, 2056, respectively.

Source · Based on the filing body and exhibits

Early Redemption Terms and Underwriting Agreement

The company said it may redeem each series of Notes prior to specified dates by paying a make-whole premium plus accrued and unpaid interest, and on or after such dates by paying a redemption price equal to 100% of the principal amount plus accrued and unpaid interest. The company entered into an Underwriting Agreement with BofA Securities, Inc., Citigroup Global Markets Inc., HSBC Securities (USA) Inc. and Morgan Stanley & Co. LLC on September 2, 2025.

Source · Based on the filing body and exhibits

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.

Source: SEC EDGAR (U.S. Securities and Exchange Commission). Item captions are the SEC's. The summary is for reference only and is not investment advice.